Beijing CytoNiche Biotechnology
PrivateLast Round
Series B
Extension
Sep 15, 2025
Total Funding Raised
$47M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Beijing CytoNiche Biotechnology operates in Healthcare & Life Sciences and is based in Beijing. Its latest recorded funding round was a Series B round in March 2022.
Beijing CytoNiche Biotechnology is a biotechnology company that provides integrated 3D cell manufacturing platforms and solutions for the cell and gene therapy industry.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Smart Manufacturing, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Beijing CytoNiche Biotechnology Comparables
Compare Beijing CytoNiche Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shenzhen Cellbri Bio-Innovation Technology Co., Ltd. | 78% | |
| Shanghai Lepure Biotech Co., Ltd. | 76% | |
| Sartorius Aktiengesellschaft | 74% |
For institutional investors. Book with your work email.
Beijing CytoNiche Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Sep 15, 2025 | ||||
| Series B | Mar 3, 2022 | ||||
| Series A Extension | Apr 28, 2021 | ||||
| Series A | Sep 2, 2020 | ||||
| Pre Seed | Aug 22, 2019 |
For institutional investors. Book with your work email.
Beijing CytoNiche Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bencao Capital | Series B, Series A Extension |
| DT Capital Partners | Series B, Series A |
| Changjiang Growth Capital | Pre Seed |
| CICC Capital | Series B Extension |
| 北京市新材料产业投资基金 | Series B Extension |
| ICBC Financial Asset Investment | Series B Extension |
| Yijing Capital | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 3, 2026
Open roles increased from 0 to 3, representing 43% of headcount.
- Feb 17, 2026
Grew 60% QoQ from 5 to 8 employees.
For institutional investors. Book with your work email.
Beijing CytoNiche Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Beijing CytoNiche Biotechnology's valuation, stock price, and market status.
Is Beijing CytoNiche Biotechnology a public or private company?
Beijing CytoNiche Biotechnology is a private company.
What is the current stock price of Beijing CytoNiche Biotechnology?
Beijing CytoNiche Biotechnology is a private company, so its shares have no public market price. Caplight tracks Beijing CytoNiche Biotechnology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Beijing CytoNiche Biotechnology worth (valuation)?
Valuation information for Beijing CytoNiche Biotechnology is not publicly available.
Can I buy Beijing CytoNiche Biotechnology stock?
Beijing CytoNiche Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Beijing CytoNiche Biotechnology's last funding round?
Beijing CytoNiche Biotechnology's most recent funding round was Series B Extension on September 15, 2025.
Who are the main investors in Beijing CytoNiche Biotechnology?
Key investors in Beijing CytoNiche Biotechnology include Bencao Capital, Gaorong Capital.
Will Beijing CytoNiche Biotechnology IPO soon?
No public IPO plans have been announced for Beijing CytoNiche Biotechnology.
How can I track Beijing CytoNiche Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades in Beijing CytoNiche Biotechnology's shares on secondary markets.